The Merchant Biotech Fund (“MBF” or “the Fund”) is up 59% for the financial year vs the ASX Healthcare 300 Index (XHK) up 6.09% over the same period. Read more.
The Merchant Biotech Fund (“MBF” or “the Fund”) is up 59% for the financial year vs the ASX Healthcare 300 Index (XHK) up 6.09% over the same period. Read more.